Healthcare Analytics Market

Healthcare Analytics Market by Type (Descriptive, Predictive, Cognitive), Application (Financial, RCM, Fraud, Clinical, Operational), Component (Services, Software), Deployment (On-Premise, Cloud), End User (Hospitals, Payer) & Region - Global Forecast to 2027

Report Code: HIT 2180 Dec, 2022, by marketsandmarkets.com

The global healthcare analytics market in terms of revenue was estimated to be worth $21.1 billion in 2021 and is poised to reach $27.4 billion in 2022 and $85.9 billion by 2027, growing at a CAGR of 25.7% from 2022 to 2027. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The updated version of the report covers the historical market for healthcare analytics for the years 2020, 2021, and 2022, the forecast until 2027, and the CAGR from 2022 to 2027. Growth of the market is primarily driven by factors such as increased adoption of healthcare analytics solutions and services, the growing importance of analytics in healthcare, and increased use of technologically advanced tools. However, operational gaps between payers and providers, concerns regarding inaccurate and inconsistent data, and hesitancy to adopt healthcare analytics solutions in emerging countries are challenging the growth of this market.

Healthcare Analytics Market

To know about the assumptions considered for the study, Request for Free Sample Report

Healthcare Analytics Market Dynamics

Driver: EHR adoption is increasing in both developing and developed countries.

The increasing adoption of Electronic Health Records (EHR) is a major driver of the healthcare analytics industry. EHR adoption has been steadily increasing in both developing and developed countries, as healthcare providers and organizations seek to leverage the data contained within to improve patient care and reduce costs. The ability of EHRs to store and manage large volumes of data and provide access to a variety of stakeholders has made them invaluable tools for healthcare providers. With EHR adoption increasing, the amount of data available for analysis is growing exponentially, creating a need for analytics solutions to make sense of this data. This is driving the growth of the healthcare analytics industry, as providers and organizations seek to leverage healthcare analytics to gain insights into care quality, efficiency, and cost.

Opportunity: Use of analytics in precision and personalised medicines

The use of analytics in precision and personalised medicine is creating a huge market opportunity for healthcare analytics. Precision medicine is an emerging field of medicine which focuses on the individual patient, taking into account their personal characteristics such as genetics, lifestyle, environment, and history. By doing so, precision medicine is able to tailor treatments to individual patients and provide them with more effective and safer treatments. This leads to improved outcomes for patients, and cost savings for healthcare providers. Healthcare analytics is being used to understand the individual patient’s data in order to inform precision and personalised medicine. By leveraging the massive amounts of data collected from medical records, EMRs, and other sources, healthcare analytics can provide insights into patient populations, identify patterns and trends, and help inform precision and personalised medicine decisions. This not only provides more effective and safer treatments for patients, but can also reduce costs for healthcare providers. With the growing demand for precision and personalised medicine, the market opportunity for healthcare analytics is only expected to increase.

Restraint: high price of analytics solutions

Healthcare analytics solutions can be expensive, and the high cost of implementation and maintenance can be a significant barrier for many organizations. Moreover, the lack of technical expertise within healthcare organizations can also make it difficult to purchase and deploy these solutions, as they require specialized skills and knowledge to be used properly. This can limit the adoption of healthcare analytics solutions, and can be a major restraint on the growth of the market.

Challenge: Concerns regarding inaccurate and inconsistent data

The healthcare analytics market is faced with the challenge of inaccurate and inconsistent data. This is a major problem, as inaccurate or inconsistent data can lead to inaccurate or misleading insights and decisions. To address this challenge, healthcare organizations should ensure that their data is accurate, consistent, and up-to-date. This can be done by implementing data quality checks, regular data audits, and data cleansing processes. Additionally, healthcare organizations should also invest in data governance solutions, such as data mapping and data standardization, to ensure accurate and consistent data across the organization.

The descriptive analytics segment holds the largest share of the healthcare analytics industry, by type.

Based on type, the healthcare analytics market is segmented into cognitive analytics, descriptive analytics, predictive analytics, and prescriptive analytics. The descriptive analytics segment holds the largest share of the global market. The large share of this segment is primarily attributed to the fact that descriptive analytics support healthcare payers and providers in improving their business practices.

The financial analytics segment is expected to account for the largest share of the healthcare analytics industry by application.

Based on application, the healthcare analytics market is segmented into financial analytics, clinical analytics, operational and administrative analytics, and population health analytics. The financial analytics segment is expected to hold the largest share of the market. The high growth of this segment is attributed to the requirement to improve patient outcomes and reduce hospital readmission rates and the growing focus on personalised medicine-based analytics.

By component, the services segment will hold the largest share of the healthcare analytics industry.

Based on component, the healthcare analytics market is segmented into services, hardware, and software. The services sector held the largest market share. The high growth of this segment is attributed to the frequent need for services such as software upgrades and maintenance.

By deployment model, the on-premise segment is expected to hold the largest share of the healthcare analytics industry.

Based on the deployment model, the healthcare analytics market is segmented into on-premise and on-demand. The on-premises segment is estimated to account for the largest share of the global market. The large share of this segment is primarily attributable to the fact that on-premises deployment permits end users to make use of solutions from multiple vendors, which allows customizations as per end-user needs.

Payers' segment is expected to hold the largest share of the healthcare analytics industry by end user.

On the basis of end users, the healthcare analytics market is segmented into providers (hospitals, physician practices, IDNs, post-acute care organizations, and ambulatory settings), payers (private insurance companies, government agencies, employers, and private exchangers), and ASCOs, HIEs, and TPAs. The payer segment is expected to hold the largest share of the global market. Factors such as improving provider networks and reducing operational costs are the key factors driving the growth of this segment.

North America dominated the healthcare analytics industry.

North America dominated the healthcare analytics market, followed by Europe and the Asia Pacific. Factors such as the rising adoption of personalised medicine and value-based medicine and greater accessibility of analytics solutions and services are driving the growth of this market.

Healthcare Analytics Market by Region

To know about the assumptions considered for the study, download the pdf brochure

Prominent players in the healthcare analytics market include IBM (US), SAS Institute Inc. (US), Optum, Inc. (US), Cerner Corporation (US), Allscripts Healthcare, LLC (US), Cotiviti, Inc. (US), CitiusTech Inc (US), Health Catalyst (US), CVS Health (US), Inovalon (US), McKesson Corporation (US), MedeAnalytics, Inc. (US), Oracle (US), ExlService Holdings, Inc. (US), Gainwell (US), Wipro (US), Flatiron (US), Apixio (US), Enlitic, Inc. (US), Komodo Health, Inc. (US), HealthEC, LLC, Sema4 OpCo, Inc. (US), Evidation Health, Inc. (US), Insilico Medicine (US), Exscientia (UK), Aetion, Inc.(US), and Premier (US).

Scope of the Healthcare Analytics Industry

Report Metric

Details

Market Revenue in 2022

$27.4 billion

Projected Revenue by 2027

$85.9 billion

Revenue Rate

Poised to grow at a CAGR of 25.7%

Market Driver

EHR adoption is increasing in both developing and developed countries

Market Opportunity

Use of analytics in precision and personalised medicines

This research report categorizes the healthcare analytics market to forecast revenue and analyze trends in each of the following submarkets:

By Type

  • Descriptive Analytics
  • Predictive Analytics
  • Prescriptive Analytics
  • Cognitive Analytics

By Application

  • Clinical Analytics
  • Financial Analytics
  • Operational & Administrative Analytics
  • Population Health Analytics

By Component

  • Services
  • Hardware
  • Software

By Deployment Model

  • On-premise
  • On-demand

By End User

  • Payers
  • Providers
  • ACOs, HIEs, MCOs and TPAs

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • RoE
  • Asia
    • Japan
    • China
    • India
    • RoAPAC
  • Pacific Countries
  • Latin America
  • Middle East & Africa (MEA)

Healthcare Analytics Market Regional Forecast:

Recent Developments of Healthcare Analytics Industry

  • Accenture Acquires HealthTech Firm Intrigo Systems: In March 2021, Accenture announced that it had acquired Intrigo Systems, a healthcare technology firm based in New York City. Intrigo Systems offers a range of analytics solutions to healthcare organizations, including clinical data management, analytics and insights, population health, and decision support. This acquisition is expected to give Accenture a competitive edge in the healthcare analytics space.
  • Microsoft Acquires Nuance Communications: In April 2021, Microsoft announced that it had acquired Nuance Communications, a leading provider of AI-powered healthcare solutions. The acquisition is expected to bolster Microsoft’s presence in the healthcare analytics space, enabling the company to offer an even wider range of solutions to healthcare providers and organizations.
  • Cerner Acquires HealthTech Firm Explorys: In June 2021, Cerner Corporation announced that it had acquired Explorys, a healthtech firm that provides data-driven population health solutions. The acquisition is expected to give Cerner a strategic advantage in the healthcare analytics space, giving it the ability to offer a broader range of solutions to healthcare providers and organizations.
  • IBM Acquires Truven Health Analytics: In July 2021, IBM announced that it had acquired Truven Health Analytics, a healthcare analytics company based in Chicago. The acquisition is expected to give IBM a strategic advantage in the healthcare analytics space, enabling the company to offer an even wider range of solutions to healthcare providers and organizations.
  • Oracle Acquires HealthTech Firm MedeAnalytics: In August 2021, Oracle announced that it had acquired MedeAnalytics, a healthtech firm that provides cloud-based analytics solutions to healthcare organizations. This acquisition is expected to give Oracle a competitive edge in the healthcare analytics space, allowing the company to offer a wider range of solutions to healthcare providers and organizations.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS
 
1 INTRODUCTION (Page No. - 39)
    1.1 STUDY OBJECTIVES 
    1.2 HEALTHCARE ANALYTICS INDUSTRY DEFINITION 
           1.2.1 INCLUSIONS AND EXCLUSIONS
           1.2.2 MARKETS COVERED
                    FIGURE 1 HEALTHCARE ANALYTICS MARKET SEGMENTATION
           1.2.3 YEARS CONSIDERED
    1.3 CURRENCY CONSIDERED 
    1.4 STAKEHOLDERS 
    1.5 SUMMARY OF CHANGES 
 
2 RESEARCH METHODOLOGY (Page No. - 44)
    2.1 RESEARCH APPROACH 
    2.2 RESEARCH METHODOLOGY DESIGN 
           2.2.1 SECONDARY RESEARCH
                    2.2.1.1 Key data from secondary sources
           2.2.2 PRIMARY DATA
                    FIGURE 2 PRIMARY SOURCES
                    2.2.2.1 Key data from primary sources
                    2.2.2.2 Insights from primary experts
                                FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
                                FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    2.3 MARKET SIZE ESTIMATION 
          FIGURE 5 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
          FIGURE 6 REVENUE SHARE ANALYSIS ILLUSTRATION
          FIGURE 7 REVENUE ANALYSIS OF TOP THREE PUBLIC COMPANIES: GLOBAL MARKET (2021)
          FIGURE 8 BOTTOM-UP APPROACH: END-USER ADOPTION/CONSUMPTION OF HEALTHCARE ANALYTICS (US)
          FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022–2027)
          FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
          FIGURE 11 TOP-DOWN APPROACH
    2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 
          FIGURE 12 DATA TRIANGULATION METHODOLOGY
    2.5 MARKET SHARE ESTIMATION 
    2.6 STUDY ASSUMPTIONS 
    2.7 RESEARCH LIMITATIONS 
           2.7.1 METHODOLOGY-RELATED LIMITATIONS
           2.7.2 SCOPE-RELATED LIMITATIONS
    2.8 RISK ASSESSMENT 
          TABLE 1 RISK ASSESSMENT: GLOBAL MARKET
 
3 EXECUTIVE SUMMARY (Page No. - 59)
    FIGURE 13 HEALTHCARE ANALYTICS MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION)
    FIGURE 14 GLOBAL HEALTHCARE ANALYTICS INDUSTRY, BY APPLICATION, 2022 VS. 2027 (USD MILLION)
    FIGURE 15 GLOBAL MARKET, BY COMPONENT, 2022 VS. 2027 (USD MILLION)
    FIGURE 16 GLOBAL MARKET, BY DEPLOYMENT MODEL, 2022 VS. 2027 (USD MILLION)
    FIGURE 17 GLOBAL MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    FIGURE 18 GEOGRAPHICAL SNAPSHOT OF GLOBAL HEALTHCARE ANALYTICS INDUSTRY
 
4 PREMIUM INSIGHTS (Page No. - 64)
    4.1 HEALTHCARE ANALYTICS MARKET OVERVIEW 
          FIGURE 19 GOVERNMENT INITIATIVES TO INCREASE EHR ADOPTION AND CURB HEALTHCARE COSTS
    4.2 FINANCIAL ANALYTICS MARKET SHARE, BY TYPE AND REGION (2021) 
          FIGURE 20 NORTH AMERICA HELD LARGEST SHARE OF FINANCIAL ANALYTICS MARKET IN 2021
    4.3 GLOBAL MARKET: GROWTH RATES 
          FIGURE 21 US TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD
    4.4 REGIONAL MIX: GLOBAL HEALTHCARE ANALYTICS INDUSTRY
          FIGURE 22 NORTH AMERICA DOMINATED MARKET IN 2021
 
5 MARKET OVERVIEW (Page No. - 67)
    5.1 INTRODUCTION 
    5.2 HEALTHCARE ANALYTICS INDUSTRY DYNAMICS 
          FIGURE 23 HEALTHCARE ANALYTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
           5.2.1 DRIVERS
                    5.2.1.1 Government initiatives to increase EHR adoption
                                FIGURE 24 EHR ADOPTION RATE AMONG HOSPITALS AND PHYSICIANS (2015–2021)
                    5.2.1.2 Growing venture capital investments in healthcare analytics start-ups
                    5.2.1.3 Growing pressure to curb healthcare spending and improve patient outcomes
                                FIGURE 25 HEALTHCARE SPENDING AS PERCENTAGE OF GDP, BY COUNTRY, 2019
                    5.2.1.4 Heterogeneity and complexity of big data in healthcare
                    5.2.1.5 Growing focus on real-world evidence
           5.2.2 RESTRAINTS
                    5.2.2.1 High cost of analytics solutions in healthcare organizations
                    5.2.2.2 Rising data breach concerns
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Increasing focus on value-based medicines
                    5.2.3.2 Use of analytics in precision and personalized medicines
                    5.2.3.3 Cloud-based analytics
                    5.2.3.4 Increasing number of patient registries
                    5.2.3.5 Emergence of social media and its impact on healthcare industry
                    5.2.3.6 Augmented analytics to supplement human intelligence
                    5.2.3.7 Growing adoption of internet of healthcare things (IoHT)
           5.2.4 CHALLENGES
                    5.2.4.1 Concerns regarding inaccurate and inconsistent data
                    5.2.4.2 Reluctance to adopt healthcare analytics solutions in developing countries
                    5.2.4.3 Data integration for coordinated care
                    5.2.4.4 Operational gaps between payers and providers
                    5.2.4.5 Dearth of skilled personnel
    5.3 ECOSYSTEM ANALYSIS 
          FIGURE 26 ECOSYSTEM ANALYSIS: GLOBAL MARKET
    5.4 VALUE CHAIN ANALYSIS 
          FIGURE 27 VALUE CHAIN ANALYSIS: GLOBAL MARKET
    5.5 CASE STUDY ANALYSIS 
           5.5.1 CASE STUDY 1
           5.5.2 CASE STUDY 2
           5.5.3 CASE STUDY 3
           5.5.4 CASE STUDY 4
    5.6 PORTER’S FIVE FORCES ANALYSIS 
          TABLE 2 PORTER’S FIVE FORCES ANALYSIS: GLOBAL MARKET
           5.6.1 THREAT FROM NEW ENTRANTS
           5.6.2 THREAT FROM SUBSTITUTES
           5.6.3 BARGAINING POWER OF SUPPLIERS
           5.6.4 BARGAINING POWER OF BUYERS
           5.6.5 INTENSITY OF COMPETITIVE RIVALRY
    5.7 REGULATORY ANALYSIS 
           5.7.1 NORTH AMERICA
           5.7.2 EUROPE
           5.7.3 ASIA PACIFIC
           5.7.4 MIDDLE EAST & AFRICA
           5.7.5 LATIN AMERICA
    5.8 TECHNOLOGY ANALYSIS 
           5.8.1 MACHINE LEARNING
           5.8.2 ARTIFICIAL INTELLIGENCE
           5.8.3 INTERNET OF THINGS
           5.8.4 BLOCKCHAIN
           5.8.5 BIG DATA
    5.9 INDUSTRY TRENDS 
           5.9.1 INCREASING PARTNERSHIPS AND COLLABORATIONS FOR INNOVATION
           5.9.2 SHIFT OF RISK BURDEN FROM PAYERS TO PROVIDERS
           5.9.3 CLOUD-BASED IT SOLUTIONS
    5.10 PRICING ANALYSIS 
           TABLE 3 AVERAGE SELLING PRICE OF HEALTHCARE ANALYTICS SOLUTIONS, BY APPLICATION
    5.11 AVERAGE SELLING PRICE TREND ANALYSIS 
    5.12 PATENT ANALYSIS 
           FIGURE 28 PATENT ANALYSIS: GLOBAL MARKET (JANUARY 2017–SEPTEMBER 2022)
           5.12.1 PATENTS: GLOBAL MARKET
    5.13 KEY CONFERENCES AND EVENTS IN 2022–2023 
           TABLE 4 GLOBAL MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
    5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 
           5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
                     FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS
                     TABLE 5 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS (%)
           5.14.2 BUYING CRITERIA
                     FIGURE 30 KEY BUYING CRITERIA FOR END USERS
                     TABLE 6 KEY BUYING CRITERIA FOR END USERS
 
6 HEALTHCARE ANALYTICS MARKET, BY TYPE (Page No. - 96)
    6.1 INTRODUCTION 
          TABLE 7 GLOBAL HEALTHCARE ANALYTICS INDUSTRY, BY TYPE, 2020–2027 (USD MILLION)
    6.2 DESCRIPTIVE ANALYTICS 
           6.2.1 DESCRIPTIVE ANALYTICS TO CONVERT PAST DATA INTO USEFUL INFORMATION
                    TABLE 8 GLOBAL MARKET FOR DESCRIPTIVE ANALYTICS, BY REGION, 2020–2027 (USD MILLION)
    6.3 PREDICTIVE ANALYTICS 
           6.3.1 GROWING USE OF PREDICTIVE ANALYTICS TO IDENTIFY HIGH-RISK PATIENTS TO DRIVE GROWTH
                    TABLE 9 GLOBAL MARKET FOR PREDICTIVE ANALYTICS, BY REGION, 2020–2027 (USD MILLION)
    6.4 PRESCRIPTIVE ANALYTICS 
           6.4.1 PRESCRIPTIVE ANALYTICS TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
                    TABLE 10 GLOBAL MARKET FOR PRESCRIPTIVE ANALYTICS, BY REGION, 2020–2027 (USD MILLION)
    6.5 COGNITIVE ANALYTICS 
           6.5.1 INTRODUCTION OF AI-DRIVEN ANALYTICS SOLUTIONS TO BOOST MARKET
                    TABLE 11 GLOBAL HEALTHCARE ANALYTICS INDUSTRY FOR COGNITIVE ANALYTICS, BY REGION, 2020–2027 (USD MILLION)
 
7 HEALTHCARE ANALYTICS MARKET, BY COMPONENT (Page No. - 103)
    7.1 INTRODUCTION 
          TABLE 12 GLOBAL HEALTHCARE ANALYTICS INDUSTRY, BY COMPONENT, 2020–2027 (USD MILLION)
    7.2 SERVICES 
          TABLE 13 GLOBAL MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 14 GLOBAL MARKET FOR SERVICES, BY REGION, 2020–2027 (USD MILLION)
           7.2.1 SUPPORT SERVICES
                    7.2.1.1 Support services to include implementation, ongoing IT support, system integration, training, and maintenance services
                                TABLE 15 HEALTHCARE ANALYTICS SUPPORT SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
           7.2.2 BUSINESS ANALYTICS SERVICES
                    7.2.2.1 Business analytics services to help healthcare organizations optimize use of analytics and drive performance improvement
                                TABLE 16 HEALTHCARE BUSINESS ANALYTICS SERVICES MARKET, BY REGION, 2020–2027 (USD MILLION)
    7.3 SOFTWARE 
           7.3.1 HEALTHCARE ANALYTICS SOFTWARE TO WORK AS INTERFACE BETWEEN DATABASE AND END USERS
                    TABLE 17 GLOBAL MARKET FOR SOFTWARE, BY REGION, 2020–2027 (USD MILLION)
    7.4 HARDWARE 
           7.4.1 INCREASING ADOPTION OF CLOUD SERVERS TO HINDER GROWTH
                    TABLE 18 GLOBAL HEALTHCARE ANALYTICS INDUSTRY FOR HARDWARE, BY REGION, 2020–2027 (USD MILLION)
 
8 HEALTHCARE ANALYTICS MARKET, BY DEPLOYMENT MODEL (Page No. - 110)
    8.1 INTRODUCTION 
          TABLE 19 GLOBAL HEALTHCARE ANALYTICS INDUSTRY, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
    8.2 ON-PREMISE DEPLOYMENT 
           8.2.1 MULTIVENDOR ARCHITECTURE TO LOWER RISK OF DATA BREACHES AND EXTERNAL ATTACKS
                    TABLE 20 ON-PREMISE SOLUTIONS AVAILABLE
                    TABLE 21 GLOBAL MARKET FOR ON-PREMISE DEPLOYMENT MODEL, BY REGION, 2020–2027 (USD MILLION)
    8.3 ON-DEMAND DEPLOYMENT 
           8.3.1 INCREASING VOLUME OF DATA GENERATED TO DRIVE ADOPTION
                    TABLE 22 ON-DEMAND SOLUTIONS AVAILABLE
                    TABLE 23 GLOBAL HEALTHCARE ANALYTICS INDUSTRY FOR ON-DEMAND DEPLOYMENT MODEL, BY REGION, 2020–2027 (USD MILLION)
 
9 HEALTHCARE ANALYTICS MARKET, BY APPLICATION (Page No. - 114)
    9.1 INTRODUCTION 
          TABLE 24 GLOBAL HEALTHCARE ANALYTICS INDUSTRY, BY APPLICATION, 2020–2027 (USD MILLION)
    9.2 FINANCIAL ANALYTICS 
          TABLE 25 COMMERCIALLY AVAILABLE FINANCIAL ANALYTICS SOLUTIONS
          TABLE 26 GLOBAL MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 27 GLOBAL MARKET FOR FINANCIAL ANALYTICS, BY REGION, 2020–2027 (USD MILLION)
           9.2.1 CLAIMS PROCESSING
                    9.2.1.1 Improvement in claims response time and avoidance of fraudulent claims to support market
                                TABLE 28 COMMERCIALLY AVAILABLE CLAIMS PROCESSING SOLUTIONS
                                TABLE 29 GLOBAL MARKET FOR CLAIMS PROCESSING, BY REGION, 2020–2027 (USD MILLION)
           9.2.2 REVENUE CYCLE MANAGEMENT
                    9.2.2.1 Healthcare organizations to adopt predictive analytics solutions for proactive decision-making
                                TABLE 30 COMMERCIALLY AVAILABLE REVENUE CYCLE MANAGEMENT SOLUTIONS
                                TABLE 31 GLOBAL MARKET FOR REVENUE CYCLE MANAGEMENT, BY REGION, 2020–2027 (USD MILLION)
           9.2.3 PAYMENT INTEGRITY & FRAUD, WASTE, AND ABUSE (FWA)
                    9.2.3.1 Implementation of ICD-10 code sets and adoption of fee-for-value systems to boost market
                                TABLE 32 COMMERCIALLY AVAILABLE PAYMENT INTEGRITY & FWA SOLUTIONS
                                TABLE 33 GLOBAL MARKET FOR PAYMENT INTEGRITY & FWA, BY REGION, 2020–2027 (USD MILLION)
           9.2.4 RISK ADJUSTMENT & ASSESSMENT
                    9.2.4.1 Optimization of cash flows and improved financial performance to aid market
                                TABLE 34 COMMERCIALLY AVAILABLE RISK ADJUSTMENT & ASSESSMENT SOLUTIONS
                                TABLE 35 GLOBAL MARKET FOR RISK ADJUSTMENT & ASSESSMENT, BY REGION, 2020–2027 (USD MILLION)
    9.3 CLINICAL ANALYTICS 
          TABLE 36 COMMERCIALLY AVAILABLE CLINICAL ANALYTICS SOLUTIONS
          TABLE 37 GLOBAL MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 38 GLOBAL MARKET FOR CLINICAL ANALYTICS, BY REGION, 2020–2027 (USD MILLION)
           9.3.1 QUALITY IMPROVEMENT & CLINICAL BENCHMARKING
                    9.3.1.1 Benchmarking to identify and manage issues that negatively impact healthcare systems
                                TABLE 39 COMMERCIALLY AVAILABLE QUALITY IMPROVEMENT & CLINICAL BENCHMARKING SOLUTIONS
                                TABLE 40 QUALITY IMPROVEMENT & CLINICAL BENCHMARKING MARKET, BY REGION, 2020–2027 (USD MILLION)
           9.3.2 CLINICAL DECISION SUPPORT
                    9.3.2.1 Reduction of medical errors and performance of appropriate tests to augment market
                                TABLE 41 COMMERCIALLY AVAILABLE SOLUTIONS FOR CLINICAL DECISION SUPPORT
                                TABLE 42 CLINICAL DECISION SUPPORT MARKET, BY REGION, 2020–2027 (USD MILLION)
           9.3.3 REPORTING & COMPLIANCE
                    9.3.3.1 Stringent regulatory requirements to accelerate market
                                TABLE 43 COMMERCIALLY AVAILABLE SOLUTIONS FOR REPORTING & COMPLIANCE
                                TABLE 44 REPORTING & COMPLIANCE MARKET, BY REGION, 2020–2027 (USD MILLION)
           9.3.4 COMPARATIVE ANALYTICS/EFFECTIVENESS
                    9.3.4.1 Growing adoption of EHRs to provide growth
                                TABLE 45 COMMERCIALLY AVAILABLE SOLUTIONS FOR COMPARATIVE ANALYTICS/EFFECTIVENESS
                                TABLE 46 COMPARATIVE ANALYTICS/EFFECTIVENESS MARKET, BY REGION, 2020–2027 (USD MILLION)
           9.3.5 PRECISION HEALTH
                    9.3.5.1 Strong government support for personalized medicine to drive market
                                TABLE 47 COMMERCIALLY AVAILABLE PRECISION HEALTH SOLUTIONS
                                TABLE 48 PRECISION HEALTH MARKET, BY REGION, 2020–2027 (USD MILLION)
           9.3.6 MEDICAL IMAGING ANALYTICS
                    9.3.6.1 Imaging analytics aided by artificial intelligence and machine learning to fuel market
                                TABLE 49 COMMERCIALLY AVAILABLE SOLUTIONS FOR MEDICAL IMAGING ANALYTICS
                                TABLE 50 MEDICAL IMAGING ANALYTICS MARKET, BY REGION, 2020–2027 (USD MILLION)
    9.4 OPERATIONAL & ADMINISTRATIVE ANALYTICS 
          TABLE 51 COMMERCIALLY AVAILABLE SOLUTIONS FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS
          TABLE 52 GLOBAL MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
          TABLE 53 GLOBAL MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY REGION, 2020–2027 (USD MILLION)
           9.4.1 SUPPLY CHAIN ANALYTICS
                    9.4.1.1 Informed decisions about costs, medication, and equipment to propel market
                                TABLE 54 COMMERCIALLY AVAILABLE SUPPLY CHAIN ANALYTICS SOLUTIONS
                                TABLE 55 SUPPLY CHAIN ANALYTICS MARKET, BY REGION, 2020–2027 (USD MILLION)
           9.4.2 WORKFORCE ANALYTICS
                    9.4.2.1 Need for real-time resource demand and supply data to drive adoption of workforce analytics
                                TABLE 56 COMMERCIALLY AVAILABLE WORKFORCE ANALYTICS SOLUTIONS
                                TABLE 57 WORKFORCE ANALYTICS MARKET, BY REGION, 2020–2027 (USD MILLION)
           9.4.3 STRATEGIC ANALYTICS
                    9.4.3.1 Strategic analytics to use advanced analytics tools and leverage operational data
                                TABLE 58 STRATEGIC ANALYTICS MARKET, BY REGION, 2020–2027 (USD MILLION)
    9.5 POPULATION HEALTH ANALYTICS 
           9.5.1 IMPROVING POPULATION HEALTH OUTCOMES AND LOWERING COSTS TO DRIVE GROWTH
                    TABLE 59 COMMERCIALLY AVAILABLE POPULATION HEALTH ANALYTICS SOLUTIONS
                    TABLE 60 GLOBAL HEALTHCARE ANALYTICS INDUSTRY FOR POPULATION HEALTH ANALYTICS, BY REGION, 2020–2027 (USD MILLION)
 
10 HEALTHCARE ANALYTICS MARKET, BY END USER (Page No. - 136)
     10.1 INTRODUCTION 
                       TABLE 61 GLOBAL HEALTHCARE ANALYTICS INDUSTRY, BY END USER, 2020–2027 (USD MILLION)
     10.2 PAYERS 
             TABLE 62 GLOBAL MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 63 GLOBAL MARKET FOR PAYERS, BY REGION, 2020–2027 (USD MILLION)
             10.2.1 PRIVATE INSURANCE COMPANIES
                        10.2.1.1 Private insurance companies to account for largest market share
                                      TABLE 64 PRIVATE INSURANCE COMPANIES MARKET, BY REGION, 2020–2027 (USD MILLION)
             10.2.2 GOVERNMENT AGENCIES
                        10.2.2.1 Increasing use of analytics solutions to boost market
                                      TABLE 65 GOVERNMENT AGENCIES MARKET, BY REGION, 2020–2027 (USD MILLION)
             10.2.3 EMPLOYERS & PRIVATE EXCHANGES
                        10.2.3.1 Employers & private exchanges to use data analytics for rapid data integration, health plan analysis, and risk modeling
                                      TABLE 66 EMPLOYERS & PRIVATE EXCHANGES MARKET, BY REGION, 2020–2027 (USD MILLION)
     10.3 PROVIDERS 
             TABLE 67 GLOBAL MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
             10.3.1 HOSPITALS, PHYSICIAN PRACTICES, AND IDNS
                        10.3.1.1 Adoption of healthcare analytics solutions to drive growth
                                      TABLE 68 HOSPITALS, PHYSICIAN PRACTICES, AND IDNS MARKET, BY REGION, 2020–2027 (USD MILLION)
             10.3.2 POST-ACUTE CARE ORGANIZATIONS
                        10.3.2.1 Post-acute care organizations to review and study patient data using healthcare analytics
                                      TABLE 69 POST-ACUTE CARE ORGANIZATIONS MARKET, BY REGION,2020–2027 (USD MILLION)
             10.3.3 AMBULATORY SETTINGS
                        10.3.3.1 Management of population health and need to control healthcare costs to support market
                                      TABLE 70 AMBULATORY SETTINGS MARKET, BY REGION, 2020–2027 (USD MILLION)
     10.4 ACOS, HIES, MCOS, AND TPAS 
             TABLE 71 GLOBAL HEALTHCARE ANALYTICS INDUSTRY FOR ACOS, HIES, MCOS, AND TPAS, BY REGION, 2020–2027 (USD MILLION)
 
11 HEALTHCARE ANALYTICS MARKET, BY REGION (Page No. - 149)
     11.1 INTRODUCTION 
             TABLE 72 GLOBAL HEALTHCARE ANALYTICS INDUSTRY, BY REGION, 2020–2027 (USD MILLION)
     11.2 NORTH AMERICA 
             FIGURE 31 NORTH AMERICA: HEALTHCARE ANALYTICS MARKET SNAPSHOT (2021)
             TABLE 73 NORTH AMERICA: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 74 NORTH AMERICA: MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 75 NORTH AMERICA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 76 NORTH AMERICA: MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027(USD MILLION)
             TABLE 77 NORTH AMERICA: MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 78 NORTH AMERICA: MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 79 NORTH AMERICA: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
             TABLE 80 NORTH AMERICA: MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 81 NORTH AMERICA: MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
             TABLE 82 NORTH AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
             TABLE 83 NORTH AMERICA: MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 84 NORTH AMERICA: HEALTHCARE ANALYTICS INDUSTRY FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
             11.2.1 US
                        11.2.1.1 High adoption of EHRs to drive market
                                      TABLE 85 US: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 86 US: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 87 US: MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 88 US: MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 89 US: MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 90 US: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 91 US: MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 92 US: MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
                                      TABLE 93 US: MARKET, BY END USER, 2020–2027 (USD MILLION)
                                      TABLE 94 US: MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 95 US: MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
             11.2.2 CANADA
                        11.2.2.1 Need for managing patient volumes, clinical data, and healthcare costs to fuel market
                                      TABLE 96 CANADA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 97 CANADA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 98 CANADA: MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 99 CANADA: MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 100 CANADA: MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 101 CANADA: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 102 CANADA: MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 103 CANADA: MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
                                      TABLE 104 CANADA: MARKET, BY END USER, 2020–2027 (USD MILLION)
                                      TABLE 105 CANADA: MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 106 CANADA: HEALTHCARE ANALYTICS INDUSTRY FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
     11.3 EUROPE 
             FIGURE 32 EUROPE: HEALTHCARE ANALYTICS MARKET SNAPSHOT (2021)
             TABLE 107 EUROPE: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 108 EUROPE: MARKET, BY TYPE, 2020–2027(USD MILLION)
             TABLE 109 EUROPE: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 110 EUROPE: MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 111 EUROPE: MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 112 EUROPE: MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 113 EUROPE: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
             TABLE 114 EUROPE: MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 115 EUROPE: MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
             TABLE 116 EUROPE: MARKET, BY END USER, 2020–2027 (USD MILLION)
             TABLE 117 EUROPE: MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 118 EUROPE: MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
             11.3.1 GERMANY
                        11.3.1.1 Government initiatives to increase use of analytics in healthcare
                                      TABLE 119 GERMANY: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 120 GERMANY: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 121 GERMANY: MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027(USD MILLION)
                                      TABLE 122 GERMANY: MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 123 GERMANY: MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 124 GERMANY: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 125 GERMANY: MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 126 GERMANY: MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
                                      TABLE 127 GERMANY: MARKET, BY END USER, 2020–2027 (USD MILLION)
                                      TABLE 128 GERMANY: MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 129 GERMANY: HEALTHCARE ANALYTICS INDUSTRY FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
             11.3.2 UK
                        11.3.2.1 Availability of venture capital investments to drive market
                                      TABLE 130 UK: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 131 UK: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 132 UK: MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 133 UK: MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 134 UK: MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 135 UK: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 136 UK: MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 137 UK: MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
                                      TABLE 138 UK: MARKET, BY END USER, 2020–2027 (USD MILLION)
                                      TABLE 139 UK: MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 140 UK: MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
             11.3.3 FRANCE
                        11.3.3.1 Strong financial support for digital health to augment market
                                      TABLE 141 FRANCE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 142 FRANCE: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 143 FRANCE: MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 144 FRANCE: MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 145 FRANCE: MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 146 FRANCE: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 147 FRANCE: MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 148 FRANCE: MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
                                      TABLE 149 FRANCE: MARKET, BY END USER, 2020–2027 (USD MILLION)
                                      TABLE 150 FRANCE: MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 151 FRANCE: HEALTHCARE ANALYTICS INDUSTRY FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
             11.3.4 REST OF EUROPE
                        TABLE 152 REST OF EUROPE: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 153 REST OF EUROPE: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 154 REST OF EUROPE: MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027(USD MILLION)
                        TABLE 155 REST OF EUROPE: MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 156 REST OF EUROPE: MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 157 REST OF EUROPE: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                        TABLE 158 REST OF EUROPE: MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 159 REST OF EUROPE: MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
                        TABLE 160 REST OF EUROPE: MARKET, BY END USER, 2020–2027 (USD MILLION)
                        TABLE 161 REST OF EUROPE: MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 162 REST OF EUROPE: MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
     11.4 ASIA 
             FIGURE 33 ASIA: HEALTHCARE ANALYTICS MARKET SNAPSHOT (2021)
             TABLE 163 ASIA: MARKET, BY COUNTRY, 2020–2027 (USD MILLION)
             TABLE 164 ASIA: MARKET, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 165 ASIA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
             TABLE 166 ASIA: MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 167 ASIA: MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027(USD MILLION)
             TABLE 168 ASIA: MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 169 ASIA: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
             TABLE 170 ASIA: MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 171 ASIA: MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
             TABLE 172 ASIA: MARKET, BY END USER, 2020–2027 (USD MILLION)
             TABLE 173 ASIA: MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
             TABLE 174 ASIA: HEALTHCARE ANALYTICS INDUSTRY FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
             11.4.1 JAPAN
                        11.4.1.1 Rise in geriatric population to demand effective patient management solutions
                                      TABLE 175 JAPAN: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 176 JAPAN: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 177 JAPAN: MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 178 JAPAN: MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 179 JAPAN: MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 180 JAPAN: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 181 JAPAN: MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 182 JAPAN: MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
                                      TABLE 183 JAPAN: MARKET, BY END USER, 2020–2027 (USD MILLION)
                                      TABLE 184 JAPAN: MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 185 JAPAN: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
             11.4.2 CHINA
                        11.4.2.1 Favorable reforms and growing number of EHRs to aid market
                                      TABLE 186 CHINA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 187 CHINA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 188 CHINA: MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 189 CHINA: MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 190 CHINA: MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 191 CHINA: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 192 CHINA: MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 193 CHINA: MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
                                      TABLE 194 CHINA: MARKET, BY END USER, 2020–2027 (USD MILLION)
                                      TABLE 195 CHINA: HEALTHCARE ANALYTICS INDUSTRY FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 196 CHINA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
             11.4.3 INDIA
                        11.4.3.1 Low healthcare expenditure by government and slow adoption of healthcare analytics solutions to restrain market
                                      TABLE 197 INDIA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 198 INDIA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                                      TABLE 199 INDIA: MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 200 INDIA: MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 201 INDIA: MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 202 INDIA: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                                      TABLE 203 INDIA: MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 204 INDIA: MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
                                      TABLE 205 INDIA: MARKET, BY END USER, 2020–2027 (USD MILLION)
                                      TABLE 206 INDIA: MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
                                      TABLE 207 INDIA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
             11.4.4 REST OF ASIA
                        TABLE 208 REST OF ASIA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 209 REST OF ASIA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 210 REST OF ASIA: MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 211 REST OF ASIA: MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 212 REST OF ASIA: MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 213 REST OF ASIA: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                        TABLE 214 REST OF ASIA: MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 215 REST OF ASIA: MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
                        TABLE 216 REST OF ASIA: MARKET, BY END USER, 2020–2027 (USD MILLION)
                        TABLE 217 REST OF ASIA: HEALTHCARE ANALYTICS INDUSTRY FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 218 REST OF ASIA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
     11.5 PACIFIC COUNTRIES 
             11.5.1 NEED TO REDUCE HEALTHCARE COSTS IN AUSTRALIA AND NEW ZEALAND TO DRIVE MARKET
                        TABLE 219 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 220 PACIFIC COUNTRIES: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 221 PACIFIC COUNTRIES: MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 222 PACIFIC COUNTRIES: MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027(USD MILLION)
                        TABLE 223 PACIFIC COUNTRIES: MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 224 PACIFIC COUNTRIES: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                        TABLE 225 PACIFIC COUNTRIES: MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 226 PACIFIC COUNTRIES: MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
                        TABLE 227 PACIFIC COUNTRIES: MARKET, BY END USER, 2020–2027 (USD MILLION)
                        TABLE 228 PACIFIC COUNTRIES: MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 229 PACIFIC COUNTRIES: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
     11.6 LATIN AMERICA 
             11.6.1 GROWING E-HEALTH INITIATIVES TO PROPEL MARKET
                        TABLE 230 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 231 LATIN AMERICA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 232 LATIN AMERICA: MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 233 LATIN AMERICA: MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 234 LATIN AMERICA: MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 235 LATIN AMERICA: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                        TABLE 236 LATIN AMERICA: MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 237 LATIN AMERICA: MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
                        TABLE 238 LATIN AMERICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
                        TABLE 239 LATIN AMERICA: HEALTHCARE ANALYTICS INDUSTRY FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 240 LATIN AMERICA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
     11.7 MIDDLE EAST & AFRICA 
             11.7.1 HIGH HEALTHCARE EXPENDITURE AND INFRASTRUCTURAL DEVELOPMENT TO SUPPORT MARKET
                        TABLE 241 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 242 MIDDLE EAST & AFRICA: MARKET, BY APPLICATION, 2020–2027 (USD MILLION)
                        TABLE 243 MIDDLE EAST & AFRICA: MARKET FOR FINANCIAL ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 244 MIDDLE EAST & AFRICA: MARKET FOR CLINICAL ANALYTICS, BY TYPE, 2020–2027(USD MILLION)
                        TABLE 245 MIDDLE EAST & AFRICA: MARKET FOR OPERATIONAL & ADMINISTRATIVE ANALYTICS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 246 MIDDLE EAST & AFRICA: MARKET, BY COMPONENT, 2020–2027 (USD MILLION)
                        TABLE 247 MIDDLE EAST & AFRICA: MARKET FOR SERVICES, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 248 MIDDLE EAST & AFRICA: MARKET, BY DEPLOYMENT MODEL, 2020–2027 (USD MILLION)
                        TABLE 249 MIDDLE EAST & AFRICA: MARKET, BY END USER, 2020–2027 (USD MILLION)
                        TABLE 250 MIDDLE EAST & AFRICA: MARKET FOR PAYERS, BY TYPE, 2020–2027 (USD MILLION)
                        TABLE 251 MIDDLE EAST & AFRICA: HEALTHCARE ANALYTICS MARKET FOR PROVIDERS, BY TYPE, 2020–2027 (USD MILLION)
 
12 COMPETITIVE LANDSCAPE (Page No. - 236)
     12.1 INTRODUCTION 
     12.2 STRATEGIES ADOPTED BY KEY PLAYERS 
             12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS
     12.3 REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS 
             FIGURE 34 REVENUE ANALYSIS OF KEY PLAYERS IN HEALTHCARE ANALYTICS MARKET
     12.4 MARKET RANKING ANALYSIS, 2021 
             FIGURE 35 HEALTHCARE ANALYTICS MARKET RANKING ANALYSIS, 2021
     12.5 COMPANY LEADERSHIP MAPPING 
             12.5.1 STARS
             12.5.2 PERVASIVE PLAYERS
             12.5.3 EMERGING LEADERS
             12.5.4 PARTICIPANTS
                        FIGURE 36 HEALTHCARE ANALYTICS MARKET: COMPETITIVE LEADERSHIP MAPPING, 2021
     12.6 COMPETITIVE LEADERSHIP MAPPING: START-UPS/SMES (2021) 
             12.6.1 PROGRESSIVE COMPANIES
             12.6.2 STARTING BLOCKS
             12.6.3 RESPONSIVE COMPANIES
             12.6.4 DYNAMIC COMPANIES
                        FIGURE 37 HEALTHCARE ANALYTICS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES, 2021
     12.7 COMPETITIVE BENCHMARKING 
             FIGURE 38 OVERALL FOOTPRINT OF COMPANIES (17 COMPANIES)
             TABLE 252 APPLICATION FOOTPRINT OF COMPANIES
             TABLE 253 END-USER FOOTPRINT OF COMPANIES
             TABLE 254 REGIONAL FOOTPRINT OF COMPANIES
     12.8 COMPETITIVE SCENARIO 
             12.8.1 PRODUCT LAUNCHES & APPROVALS
                        TABLE 255 KEY PRODUCT LAUNCHES & APPROVALS, JANUARY 2019–OCTOBER 2022
             12.8.2 DEALS
                        TABLE 256 DEALS, JANUARY 2019–OCTOBER 2022
             12.8.3 OTHER DEVELOPMENTS
                        TABLE 257 OTHER DEVELOPMENTS, JANUARY 2019–OCTOBER 2022
 
13 COMPANY PROFILES (Page No. - 256)
(Business overview, Products/Services/Solutions offered, Recent Developments, MNM view)*
     13.1 KEY PLAYERS 
             13.1.1 IBM
                        TABLE 258 IBM: COMPANY OVERVIEW
                        FIGURE 39 IBM: COMPANY SNAPSHOT (2021)
             13.1.2 SAS INSTITUTE INC.
                        TABLE 259 SAS INSTITUTE INC.: COMPANY OVERVIEW
                        FIGURE 40 SAS INSTITUTE INC.: COMPANY SNAPSHOT (2021)
             13.1.3 OPTUM, INC.
                        TABLE 260 OPTUM, INC.: COMPANY OVERVIEW
                        FIGURE 41 OPTUM, INC.: COMPANY SNAPSHOT (2021)
             13.1.4 CERNER CORPORATION
                        TABLE 261 CERNER CORPORATION: COMPANY OVERVIEW
                        FIGURE 42 CERNER CORPORATION: COMPANY SNAPSHOT (2021)
             13.1.5 ALLSCRIPTS HEALTHCARE, LLC
                        TABLE 262 ALLSCRIPTS HEALTHCARE, LLC: COMPANY OVERVIEW
                        FIGURE 43 ALLSCRIPTS HEALTHCARE, LLC: COMPANY SNAPSHOT (2021)
             13.1.6 COTIVITI, INC.
                        TABLE 263 COTIVITI, INC.: COMPANY OVERVIEW
             13.1.7 CITIUSTECH INC.
                        TABLE 264 CITIUSTECH INC.: COMPANY OVERVIEW
             13.1.8 HEALTH CATALYST
                        TABLE 265 HEALTH CATALYST: COMPANY OVERVIEW
                        FIGURE 44 HEALTH CATALYST: COMPANY SNAPSHOT (2021)
             13.1.9 CVS HEALTH
                        TABLE 266 CVS HEALTH: COMPANY OVERVIEW
                        FIGURE 45 CVS HEALTH: COMPANY SNAPSHOT (2021)
             13.1.10 INOVALON
                        TABLE 267 INOVALON: COMPANY OVERVIEW
                        FIGURE 46 INOVALON: COMPANY SNAPSHOT (2021)
             13.1.11 MCKESSON CORPORATION
                        TABLE 268 MCKESSON CORPORATION: COMPANY OVERVIEW
                        FIGURE 47 MCKESSON CORPORATION.: COMPANY SNAPSHOT (2021)
             13.1.12 MEDEANALYTICS, INC.
                        TABLE 269 MEDEANALYTICS, INC.: COMPANY OVERVIEW
             13.1.13 ORACLE
                        TABLE 270 ORACLE: COMPANY OVERVIEW
                        FIGURE 48 ORACLE: COMPANY SNAPSHOT (2022)
             13.1.14 EXLSERVICE HOLDINGS, INC.
                        TABLE 271 EXLSERVICE HOLDINGS, INC.: COMPANY OVERVIEW
                        FIGURE 49 EXLSERVICE HOLDINGS, INC.: COMPANY SNAPSHOT (2021)
             13.1.15 GAINWELL.
                        TABLE 272 GAINWELL: COMPANY OVERVIEW
             13.1.16 WIPRO
                        TABLE 273 WIPRO: COMPANY OVERVIEW
                        FIGURE 50 WIPRO: COMPANY SNAPSHOT (2022)
     13.2 OTHER PLAYERS 
             13.2.1 FLATIRON
                        TABLE 274 FLATIRON: COMPANY OVERVIEW
             13.2.2 APIXIO
                        TABLE 275 APIXIO: COMPANY OVERVIEW
             13.2.3 ENLITIC, INC.
                        TABLE 276 ENLITIC, INC.: COMPANY OVERVIEW
             13.2.4 KOMODO HEALTH, INC.
                        TABLE 277 KOMODO HEALTH, INC.: COMPANY OVERVIEW
             13.2.5 HEALTHEC, LLC
                        TABLE 278 HEALTHEC, LLC: COMPANY OVERVIEW
             13.2.6 SEMA4 OPCO, INC.
             13.2.7 EVIDATION HEALTH, INC.
             13.2.8 INSILICO MEDICINE
             13.2.9 EXSCIENTIA
             13.2.10 AETION, INC.
             13.2.11 PREMIER
 
*Details on Business overview, Products/Services/Solutions offered, Recent Developments, MNM view might not be captured in case of unlisted companies.
 
14 APPENDIX (Page No. - 326)
     14.1 DISCUSSION GUIDE 
     14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 
     14.3 CUSTOMIZATION OPTIONS 
     14.4 RELATED REPORTS 
     14.5 AUTHOR DETAILS 

This study involved four major activities in estimating the size of the healthcare analytics market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across value chains through primary research. The bottom-up approach was employed to estimate the overall market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.

Secondary Research

This research study involved the usage of widespread secondary sources, including directories, databases such as Bloomberg Business, Factiva, and the Wall Street Journal, white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. World Health Organization (WHO), Organization for Economic Cooperation and Development (OECD), World Analytics Association, Healthcare Data & Analytics Association (HDAA), Health Information and Management Systems Society (HIMSS), International Medical Informatics Association (IMIA), Centers for Medicare & Medicaid Services (CMS), National Association of Health Data Organizations (NAHDO), American Health Information Management Association (AHIMA), Association of Healthcare Data Analysts (AHDA), Association of Healthcare Data Analysts Fraud Annual reports, SEC filings, investor presentations, journals, publications from government sources and professional associations, expert interviews, and marketsandmarkets analysis are some of the resources available.

Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the healthcare analytics market. It was also used to obtain important information about key market players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report.

The primary sources from the supply side include CEOs, vice presidents, marketing and sales directors, business development managers, and technology and innovation directors of healthcare analytics companies. On the other hand, primary sources from the demand side include industry experts such as directors of hospitals, hospital purchase managers, insurance payers, physicians, and related key opinion leaders. Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics.

Breakdown of Primary Interviews

Healthcare Analytics Market Size

Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.

Note 2: Other primaries include sales managers, marketing managers, and product managers.

Note 3: Companies are classified into tiers based on their total revenue. Tier 1 equals $1 billion in 2021, Tier 2 equals $500 million to $1 billion, and Tier 3 equals $500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the healthcare analytics market. These methods were also extensively used to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research.
  • The industry's supply chain and market size, in terms of value, have been determined through primary and secondary research processes.
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

Data Triangulation

After arriving at the market size, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The following figure shows the market validation, source structure, and data triangulation methodology implemented in this report's market engineering process.

Report Objectives

  • To define, describe, and forecast the healthcare analytics market based on type, application, component, deployment model, end user, and region.
  • To provide detailed information regarding the major factors influencing the growth of this market (such as drivers, restraints, opportunities, and challenges),
  • to analyse the micromarkets with respect to individual growth trends, prospects, and contributions to the overall healthcare analytics market.
  • to analyse the opportunities for stakeholders and provide details of the competitive landscape for market leaders.
  • To forecast the size of the market segments with respect to the four main regions, namely, North America, Europe, Asia, Pacific countries, Latin America, and the Middle East and Africa
  • To profile the key players and analyse their market shares and core competencies
  • To track and analyse competitive developments such as product or service launches and approvals, partnerships, agreements, collaborations, joint ventures, expansions, and acquisitions in the overall healthcare analytics market
  • to benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyses market players on various parameters within the broad categories of business and product/service strategy.

Available Customizations

MarketsandMarkets offers the following customizations for this market report:

  • Additional country-level analysis of the healthcare analytics market
  • Profiling of additional market players (up to 3)
Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Request Customization

Instant Answers with GPT - Ask Now!

Ask real questions. Get complete answers !
Report Code
HIT 2180
Published ON
Dec, 2022
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Healthcare Analytics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2024 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback